What ResMed Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 5 | 31 |
| Total trades | 11 | 75 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 75 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rider Michael J | Global General Counsel | Oct 23 | Open-market sale · S | −400 | $255.00 | −$102K | 12,318 |
| Farrell Michael J. | Chairman and CEO | Oct 07 | Open-market sale · S | −4,991 | $226.33 | −$1.13M | 479,803 |
| Farrell Michael J. | Chairman and CEO | Oct 07 | Exercise / conversion · M | +4,991 | $146.34 | +$730K | 484,794 |
| Farrell Peter C | Director | Sep 02 | Open-market sale · S | −970 | $234.73 | −$228K | 51,803 |
| Bloomer Aaron | Chief Financial Officer | Aug 14 | Grant / award · A | +9,072 | — | — | 9,072 |
| Leong Justin | Chief Product Officer | Aug 14 | Grant / award · A | +6,461 | — | — | 35,489 |
| Farrell Michael J. | Chairman and CEO | Aug 14 | Grant / award · A | +13,547 | — | — | 479,803 |
| Rider Michael J | Global General Counsel | Aug 14 | Grant / award · A | +3,230 | — | — | 12,718 |
| Farrell Michael J. | Chairman and CEO | Aug 07 | Open-market sale · S | −4,991 | $205.69 | −$1.03M | 466,256 |
| Farrell Michael J. | Chairman and CEO | Aug 07 | Exercise / conversion · M | +4,991 | $146.34 | +$730K | 471,247 |
| Farrell Peter C | Director | Aug 05 | Open-market sale · S | −8,000 | $225.00 | −$1.8M | 52,773 |
| Farrell Michael J. | Chairman and CEO | Jul 07 | Open-market sale · S | −4,991 | $218.55 | −$1.09M | 466,223 |
| Farrell Michael J. | Chairman and CEO | Jul 07 | Exercise / conversion · M | +4,991 | $146.34 | +$730K | 471,214 |
| Farrell Michael J. | Chairman and CEO | Jun 08 | Open-market sale · S | −4,991 | $193.96 | −$968K | 466,256 |
| Farrell Michael J. | Chairman and CEO | Jun 08 | Exercise / conversion · M | +4,991 | $146.34 | +$730K | 471,214 |
| Rider Michael J | Global General Counsel | Jun 01 | Withheld — tax / exercise cost · F | −269 | $190.57 | −$51.2K | 9,488 |
| Farrell Michael J. | Chairman and CEO | May 07 | Open-market sale · S | −4,991 | $207.82 | −$1.04M | 466,223 |
| Farrell Michael J. | Chairman and CEO | May 07 | Exercise / conversion · M | +4,991 | $146.34 | +$730K | 471,214 |
| Farrell Michael J. | Chairman and CEO | Apr 07 | Open-market sale · S | −4,991 | $225.50 | −$1.13M | 466,223 |
| Farrell Michael J. | Chairman and CEO | Apr 07 | Exercise / conversion · M | +4,991 | $146.34 | +$730K | 471,214 |
Loading...
